Title : Anticonvulsant effect of GMP depends on its conversion to guanosine.

Pub. Date : 2004 Apr 16

PMID : 15044076






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Intracerebroventricular treatment with 960 nmol GMP prevented 80% of seizures and the 5"-nucleotidase inhibitor alpha-beta-methyleneadenosine 5"-diphosphate (AOPCP), when injected 3 min before, reduced this anticonvulsant effect to 30% protection as well as significantly decreased the conversion of GMP into guanosine measured in the CSF. Guanosine Monophosphate 5'-nucleotidase ecto Homo sapiens
2 Intracerebroventricular treatment with 960 nmol GMP prevented 80% of seizures and the 5"-nucleotidase inhibitor alpha-beta-methyleneadenosine 5"-diphosphate (AOPCP), when injected 3 min before, reduced this anticonvulsant effect to 30% protection as well as significantly decreased the conversion of GMP into guanosine measured in the CSF. Guanosine Monophosphate 5'-nucleotidase ecto Homo sapiens
3 This study shows that the previously reported effect of GMP as an anticonvulsant seems to be related to its ability to generate guanosine through the action of ecto-5"-nucleotidase. Guanosine Monophosphate 5'-nucleotidase ecto Homo sapiens